Literature DB >> 16365407

Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival.

Maria Pihlgren1, Mathieu Friedli, Chantal Tougne, Anne-Françoise Rochat, Paul-Henri Lambert, Claire-Anne Siegrist.   

Abstract

In human infants (<1 year), circulating IgG Abs elicited in response to most T-dependent Ags rapidly decline and return to baseline within a few months after immunization for yet-unknown reasons. In mice immunized between 1 and 4 wk of age, a limited establishment of the bone marrow (BM) pool of long-lived plasma cells is observed. In this study, we show that tetanus toxoid (TT)-specific plasmablasts generated in the spleen are efficiently attracted in vitro and in vivo toward early-life BM stromal cells, which express adult levels of CXCL12. Similarly, adoptively transferred TT plasmablasts efficiently reach the BM compartment of 2-wk-old and adult mice. In contrast, TT plasmablasts fail to persist in the early-life BM compartment, as indicated by the persistence of a significantly lower number of TT plasmablasts in the early-life compartment than in the adult BM compartment 48 h after transfer. This limited persistence is associated with an increased rate of in vivo apoptosis of TT-specific plasmablasts that have reached the early-life BM and with a significantly lower survival rate of TT-specific plasmablasts cocultured on early-life BM stromal cells compared with adult BM stromal cells. Thus, early-life BM stromal cells fail to provide the molecular signals that support plasmablast survival and differentiation into surviving plasma cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16365407     DOI: 10.4049/jimmunol.176.1.165

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Balance between early life tolerance and sensitization in allergy: dependence on the timing and intensity of prenatal and postnatal allergen exposure of the mother.

Authors:  Ana Elisa Fusaro; Cyro Alves de Brito; Eliana Futata Taniguchi; Bruno Pacola Muniz; Jefferson Russo Victor; Noemia Mie Orii; Alberto José da Silva Duarte; Maria Notomi Sato
Journal:  Immunology       Date:  2008-12-18       Impact factor: 7.397

2.  Predicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria.

Authors:  Olivia C Finney; Samuel A Danziger; Douglas M Molina; Marissa Vignali; Aki Takagi; Ming Ji; Danielle I Stanisic; Peter M Siba; Xiawu Liang; John D Aitchison; Ivo Mueller; Malcolm J Gardner; Ruobing Wang
Journal:  Mol Cell Proteomics       Date:  2014-07-14       Impact factor: 5.911

3.  The evolution of greater humoral immunity in females than males: implications for vaccine efficacy.

Authors:  Ashley L Fink; Sabra L Klein
Journal:  Curr Opin Physiol       Date:  2018-03-29

4.  Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.

Authors:  Dominic F Kelly; Matthew D Snape; Kirsten P Perrett; Elizabeth A Clutterbuck; Susan Lewis; Geraldine Blanchard Rohner; Meryl Jones; Ly-Mee Yu; Andrew J Pollard
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

5.  Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax.

Authors:  Jiraprapa Wipasa; Chaisuree Suphavilai; Lucy C Okell; Jackie Cook; Patrick H Corran; Kanitta Thaikla; Witaya Liewsaree; Eleanor M Riley; Julius Clemence R Hafalla
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

6.  Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study.

Authors:  M D Snape; D F Kelly; S Lewis; C Banner; L Kibwana; C E Moore; L Diggle; T John; L M Yu; R Borrow; A Borkowski; C Nau; A J Pollard
Journal:  BMJ       Date:  2008-06-05

7.  Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific.

Authors:  Onome J Akpogheneta; Nancy O Duah; Kevin K A Tetteh; Samuel Dunyo; David E Lanar; Margaret Pinder; David J Conway
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

8.  Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine.

Authors:  Elizabeth A Clutterbuck; Sarah Oh; Mainga Hamaluba; Sharon Westcar; Peter C L Beverley; Andrew J Pollard
Journal:  Clin Vaccine Immunol       Date:  2007-11-21

9.  Antibodies generated against conserved antigens expressed by bacteria and allergen-bearing fungi suppress airway disease.

Authors:  Nicholas W Kin; Emily K Stefanov; Brian L P Dizon; John F Kearney
Journal:  J Immunol       Date:  2012-07-25       Impact factor: 5.422

10.  An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Authors:  Syed Muaz Khalil; Daniel R Tonkin; Andrew T Snead; Griffith D Parks; Robert E Johnston; Laura J White
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.